2nd Quarter - Report

CONSTANTINE CANNON, LLP for AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13)

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

S. 515, H.R. 1260 - patent reform S. 369, H.R. 1706 - patent settlements

Foreign entity interest: S. 515, H.R. 1260 - patent reform S. 369, H.R. 1706 - patent settlements

LobbyistCovered position, as disclosed
STEPHEN S ANDERSON —
W STEPHEN CANNON —
JOSEPH H GIBSON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 515 (111th), H.R. 1706 (111th), S. 369 (111th), H.R. 1260 (111th)

Health Issues HCR

S. 525, H.R. 1298 - drug reimportation; S. 301 - physicians payments; H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs; H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; Anti-counterfeiting legislation concerning drugs; Health care reform.

Foreign entity interest: S. 525, H.R. 1298 - drug reimportation; S. 301 - physicians payments; H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs; H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; Anti-counterfeiting legislation concerning drugs; Health care reform.

LobbyistCovered position, as disclosed
STEPHEN S ANDERSON —
W STEPHEN CANNON —
JOSEPH H GIBSON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1359 (111th), H.R. 1298 (111th), H.R. 1191 (111th), S. 1336 (111th), S. 525 (111th), S. 726 (111th), H.R. 1548 (111th), H.R. 1427 (111th), S. 1292 (111th), S. 301 (111th)

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
H. LUNDBECK A/S Denmark Denmark 12.5% $7,500

Affiliated organisations

OrganisationLocation
LUNDBECK INC. Deerfield, IL, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.